In this article
Impact of Gut Microbes on Drug Efficacy
According to a study by the University College London (UCL) on how nematodes and microorganisms treat drugs and nutrients, the activity of anticancer drugs depends on the type of bacteria that live in the intestine.
Research Methodology and Clinical Implications
This finding highlights the potential benefits of adjusting intestinal bacteria and diet to improve the prognosis of cancer treatment and understanding the value of individual differences in drug use.
This latest study, published in the journal Cell, reports a new and efficient screening method that can explain the complex relationship between host organisms, gut microbes, and drug effects.
The treatment effect of patients with varies greatly. We want to know whether this will be caused by microorganisms changing the body’s process of processing drugs. We have developed a rigorous test system that can be used for pre-clinical screening of drug interactions between the host and microorganisms, or for designing medicinal bacteria, which will make the treatment method change dramatically.
The research team found that if the host-microbe-drug interaction is not taken into account, the combined treatment of may be limited.
We have highlighted a critical missing piece about how drugs treat diseases. We plan to continue in-depth research in this area to confirm which microorganisms will affect human drug activity, and through the supervision of dietary supplements, may have a huge impact on the prognosis of cancer treatment.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
About Alysha Mendossa
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.